Cochrane Abstracts
Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Depot Medroxyprogesterone Versus Norethisterone Oenanthate for Long‐acting Progestogenic Contraception." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Depot_medroxyprogesterone_versus_Norethisterone_oenanthate_for_long‐acting_progestogenic_contraception_. Accessed 01 October 2023.
Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Depot_medroxyprogesterone_versus_Norethisterone_oenanthate_for_long‐acting_progestogenic_contraception_. Accessed October 1, 2023.
Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Depot_medroxyprogesterone_versus_Norethisterone_oenanthate_for_long‐acting_progestogenic_contraception_
Depot Medroxyprogesterone Versus Norethisterone Oenanthate for Long‐acting Progestogenic Contraception [Internet]. In: Cochrane Abstracts. [cited 2023 October 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Depot_medroxyprogesterone_versus_Norethisterone_oenanthate_for_long‐acting_progestogenic_contraception_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
ID - 433863
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433863/all/Depot_medroxyprogesterone_versus_Norethisterone_oenanthate_for_long‐acting_progestogenic_contraception_
DB - Evidence Central
DP - Unbound Medicine
ER -
